{"id":2027,"date":"2025-02-07T20:44:59","date_gmt":"2025-02-07T20:44:59","guid":{"rendered":"https:\/\/barsoums.ca\/kgkbeta\/?p=2027"},"modified":"2025-02-13T15:36:15","modified_gmt":"2025-02-13T15:36:15","slug":"kgk-contracted-by-hofseth-biocare-for-phase-2-clinical-trial-for-easing-covid-19-complications-in-former-smokers","status":"publish","type":"post","link":"https:\/\/barsoums.ca\/kgkbeta\/kgk-contracted-by-hofseth-biocare-for-phase-2-clinical-trial-for-easing-covid-19-complications-in-former-smokers\/","title":{"rendered":"KGK Contracted by Hofseth Biocare for Phase 2 Clinical Trial for Easing COVID-19 Complications in Former Smokers"},"content":{"rendered":"\n<p>May 26, 2020 \u2013 KGK Science is developing a protocol with Hofseth Biocare for an accelerated phase 2 clinical trial assessing Hofseth\u2019s CARDIO soft gels, a natural salmon oil-based reducer of eosinophil effector function, as a treatment for patients with Acute Respiratory Distress Syndrome (ARDS) caused by the SARS-CoV-2 virus. The clinical trial will examine the progression from mild to severe COVID-19 in SARS-CoV-2 infected patients who identify as former smokers and\/or steroid-resistant asthma patients currently hospitalized due to the severity of their infection.<\/p>\n\n\n\n<p>The single-center, randomized, comparator-controlled, open-label, parallel study will assess 100 hospitalized patients over a period of 28 days. The patients will receive the best current antiviral standard of care (BSC) in the placebo arm and BSC+CARDIO soft gels in the treatment arm with the primary endpoint being the number of days on assisted ventilation.<\/p>\n\n\n\n<p>Publications from the U.S. Centers for Disease Control and Prevention (CDC) show former smokers to be at particularly high risk for COVID-19-based ARDS progression into ICU care. As such, this population has been chosen to examine the efficacy of CARDIO in reducing the need for mechanical respiratory support. The study will also examine the alleviation of respiratory symptoms and the reduction of mortality in this high-risk population.<\/p>\n\n\n\n<p>\u201cKGK Science is proud to be working alongside our colleagues in the clinical research community during this unprecedented global health crisis,\u201d says Najla Guthrie, President and CEO at KGK. \u201cThe potential for natural therapeutic treatments for alleviating symptoms and possibly reducing the spread of COVID-19 are far-reaching and we are pleased to be able to offer our expertise and services to facilitate this much-needed research.\u201d<\/p>\n\n\n\n<p>KGK\u2019s regulatory team, led by former U.S. FDA Regulator Dr. Corey Hilmas, will be submitting the Clinical Trial Application to the Natural and Non-prescription Health Products Directorate (NNHPD) of Health Canada for an expedited review under a new measure put in place by the government agency to fight the outbreak of COVID-19. Following regulatory approvals, the trial will begin patient recruitment in partnership with select hospitals in Ontario.<\/p>\n\n\n\n<p>More About This Trial:<\/p>\n\n\n\n<p><a href=\"https:\/\/www.globenewswire.com\/news-release\/2020\/05\/26\/2038332\/0\/en\/Hofseth-Biocare-ASA-HBC-has-begun-protocol-development-for-its-accelerated-Phase-2-clinical-trial-with-OmeGo-to-decrease-Acute-Respiratory-Distress-Syndrome-and-the-need-for-assist.html\" target=\"_blank\" rel=\"noreferrer noopener\">Global News Wire: Hofseth Biocare ASA: HBC has begun protocol development for its accelerated Phase 2 clinical trial with OmeGo\u00ae to decrease Acute Respiratory Distress Syndrome and the need for assisted respiration in COVID-19 patients<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/www.nutritioninsight.com\/news\/hofseth-biocare-investigates-salmon-oil-for-easing-covid-19-complications.html\" target=\"_blank\" rel=\"noreferrer noopener\">Nutrition Insight: Hofseth BioCare investigates salmon oil for easing COVID-19 complications<\/a><\/p>\n\n\n\n<p>Contact: Lauren Redman, Director of Marketing | (519) 438-9374 x 254 |&nbsp;<a href=\"mailto:lredman@kgkscience.com\">lredman@kgkscience.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>May 26, 2020 \u2013 KGK Science is developing a protocol with Hofseth Biocare for an accelerated phase 2 clinical trial assessing Hofseth\u2019s CARDIO soft gels, a natural salmon oil-based reducer of eosinophil effector function, as a treatment for patients with Acute Respiratory Distress Syndrome (ARDS) caused by the SARS-CoV-2 virus. The clinical trial will examine [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":2637,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[23],"tags":[],"class_list":["post-2027","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-press-release"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.4 (Yoast SEO v27.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>KGK Contracted by Hofseth Biocare for Phase 2 Clinical Trial for Easing COVID-19 Complications in Former Smokers - KGK Science Inc.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/barsoums.ca\/kgkbeta\/kgk-contracted-by-hofseth-biocare-for-phase-2-clinical-trial-for-easing-covid-19-complications-in-former-smokers\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"KGK Contracted by Hofseth Biocare for Phase 2 Clinical Trial for Easing COVID-19 Complications in Former Smokers\" \/>\n<meta property=\"og:description\" content=\"May 26, 2020 \u2013 KGK Science is developing a protocol with Hofseth Biocare for an accelerated phase 2 clinical trial assessing Hofseth\u2019s CARDIO soft gels, a natural salmon oil-based reducer of eosinophil effector function, as a treatment for patients with Acute Respiratory Distress Syndrome (ARDS) caused by the SARS-CoV-2 virus. The clinical trial will examine [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/barsoums.ca\/kgkbeta\/kgk-contracted-by-hofseth-biocare-for-phase-2-clinical-trial-for-easing-covid-19-complications-in-former-smokers\/\" \/>\n<meta property=\"og:site_name\" content=\"KGK Science Inc.\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/KGKScience\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-07T20:44:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-13T15:36:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/barsoums.ca\/kgkbeta\/wp-content\/uploads\/2025\/02\/AdobeStock_527001674-scaled.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1702\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Claire Jack\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@kgkscience\" \/>\n<meta name=\"twitter:site\" content=\"@kgkscience\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Claire Jack\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/barsoums.ca\\\/kgkbeta\\\/kgk-contracted-by-hofseth-biocare-for-phase-2-clinical-trial-for-easing-covid-19-complications-in-former-smokers\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/barsoums.ca\\\/kgkbeta\\\/kgk-contracted-by-hofseth-biocare-for-phase-2-clinical-trial-for-easing-covid-19-complications-in-former-smokers\\\/\"},\"author\":{\"name\":\"Claire Jack\",\"@id\":\"https:\\\/\\\/barsoums.ca\\\/kgkbeta\\\/#\\\/schema\\\/person\\\/ed46640f8cbb9d96d274f1a6c6e8591b\"},\"headline\":\"KGK Contracted by Hofseth Biocare for Phase 2 Clinical Trial for Easing COVID-19 Complications in Former Smokers\",\"datePublished\":\"2025-02-07T20:44:59+00:00\",\"dateModified\":\"2025-02-13T15:36:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/barsoums.ca\\\/kgkbeta\\\/kgk-contracted-by-hofseth-biocare-for-phase-2-clinical-trial-for-easing-covid-19-complications-in-former-smokers\\\/\"},\"wordCount\":416,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/barsoums.ca\\\/kgkbeta\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/barsoums.ca\\\/kgkbeta\\\/kgk-contracted-by-hofseth-biocare-for-phase-2-clinical-trial-for-easing-covid-19-complications-in-former-smokers\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/barsoums.ca\\\/kgkbeta\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/AdobeStock_527001674-scaled.jpeg\",\"articleSection\":[\"Press Release\"],\"inLanguage\":\"en\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/barsoums.ca\\\/kgkbeta\\\/kgk-contracted-by-hofseth-biocare-for-phase-2-clinical-trial-for-easing-covid-19-complications-in-former-smokers\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/barsoums.ca\\\/kgkbeta\\\/kgk-contracted-by-hofseth-biocare-for-phase-2-clinical-trial-for-easing-covid-19-complications-in-former-smokers\\\/\",\"url\":\"https:\\\/\\\/barsoums.ca\\\/kgkbeta\\\/kgk-contracted-by-hofseth-biocare-for-phase-2-clinical-trial-for-easing-covid-19-complications-in-former-smokers\\\/\",\"name\":\"KGK Contracted by Hofseth Biocare for Phase 2 Clinical Trial for Easing COVID-19 Complications in Former Smokers - KGK Science Inc.\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/barsoums.ca\\\/kgkbeta\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/barsoums.ca\\\/kgkbeta\\\/kgk-contracted-by-hofseth-biocare-for-phase-2-clinical-trial-for-easing-covid-19-complications-in-former-smokers\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/barsoums.ca\\\/kgkbeta\\\/kgk-contracted-by-hofseth-biocare-for-phase-2-clinical-trial-for-easing-covid-19-complications-in-former-smokers\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/barsoums.ca\\\/kgkbeta\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/AdobeStock_527001674-scaled.jpeg\",\"datePublished\":\"2025-02-07T20:44:59+00:00\",\"dateModified\":\"2025-02-13T15:36:15+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/barsoums.ca\\\/kgkbeta\\\/kgk-contracted-by-hofseth-biocare-for-phase-2-clinical-trial-for-easing-covid-19-complications-in-former-smokers\\\/#breadcrumb\"},\"inLanguage\":\"en\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/barsoums.ca\\\/kgkbeta\\\/kgk-contracted-by-hofseth-biocare-for-phase-2-clinical-trial-for-easing-covid-19-complications-in-former-smokers\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en\",\"@id\":\"https:\\\/\\\/barsoums.ca\\\/kgkbeta\\\/kgk-contracted-by-hofseth-biocare-for-phase-2-clinical-trial-for-easing-covid-19-complications-in-former-smokers\\\/#primaryimage\",\"url\":\"https:\\\/\\\/barsoums.ca\\\/kgkbeta\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/AdobeStock_527001674-scaled.jpeg\",\"contentUrl\":\"https:\\\/\\\/barsoums.ca\\\/kgkbeta\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/AdobeStock_527001674-scaled.jpeg\",\"width\":2560,\"height\":1702,\"caption\":\"Male doctor looks anatomical model lung in clinic room. Working as doctor during pandemic covid 19 concept.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/barsoums.ca\\\/kgkbeta\\\/kgk-contracted-by-hofseth-biocare-for-phase-2-clinical-trial-for-easing-covid-19-complications-in-former-smokers\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/barsoums.ca\\\/kgkbeta\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"KGK Contracted by Hofseth Biocare for Phase 2 Clinical Trial for Easing COVID-19 Complications in Former Smokers\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/barsoums.ca\\\/kgkbeta\\\/#website\",\"url\":\"https:\\\/\\\/barsoums.ca\\\/kgkbeta\\\/\",\"name\":\"KGK Science Inc.\",\"description\":\"Advancing Health &amp; Wellness Through Clinical Research\",\"publisher\":{\"@id\":\"https:\\\/\\\/barsoums.ca\\\/kgkbeta\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/barsoums.ca\\\/kgkbeta\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/barsoums.ca\\\/kgkbeta\\\/#organization\",\"name\":\"KGK Science Inc.\",\"url\":\"https:\\\/\\\/barsoums.ca\\\/kgkbeta\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en\",\"@id\":\"https:\\\/\\\/barsoums.ca\\\/kgkbeta\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/barsoums.ca\\\/kgkbeta\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/cropped-kgk-logo.png\",\"contentUrl\":\"https:\\\/\\\/barsoums.ca\\\/kgkbeta\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/cropped-kgk-logo.png\",\"width\":1200,\"height\":529,\"caption\":\"KGK Science Inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/barsoums.ca\\\/kgkbeta\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/KGKScience\",\"https:\\\/\\\/x.com\\\/kgkscience\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/kgkscienceinc.\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/barsoums.ca\\\/kgkbeta\\\/#\\\/schema\\\/person\\\/ed46640f8cbb9d96d274f1a6c6e8591b\",\"name\":\"Claire Jack\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/65f555cf6e46eb32eed32e1c0f73bf1d2dbdfee55eacc84ccf8ff95a9566f96f?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/65f555cf6e46eb32eed32e1c0f73bf1d2dbdfee55eacc84ccf8ff95a9566f96f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/65f555cf6e46eb32eed32e1c0f73bf1d2dbdfee55eacc84ccf8ff95a9566f96f?s=96&d=mm&r=g\",\"caption\":\"Claire Jack\"},\"url\":\"https:\\\/\\\/barsoums.ca\\\/kgkbeta\\\/author\\\/cjack\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"KGK Contracted by Hofseth Biocare for Phase 2 Clinical Trial for Easing COVID-19 Complications in Former Smokers - KGK Science Inc.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/barsoums.ca\/kgkbeta\/kgk-contracted-by-hofseth-biocare-for-phase-2-clinical-trial-for-easing-covid-19-complications-in-former-smokers\/","og_locale":"en_US","og_type":"article","og_title":"KGK Contracted by Hofseth Biocare for Phase 2 Clinical Trial for Easing COVID-19 Complications in Former Smokers","og_description":"May 26, 2020 \u2013 KGK Science is developing a protocol with Hofseth Biocare for an accelerated phase 2 clinical trial assessing Hofseth\u2019s CARDIO soft gels, a natural salmon oil-based reducer of eosinophil effector function, as a treatment for patients with Acute Respiratory Distress Syndrome (ARDS) caused by the SARS-CoV-2 virus. The clinical trial will examine [&hellip;]","og_url":"https:\/\/barsoums.ca\/kgkbeta\/kgk-contracted-by-hofseth-biocare-for-phase-2-clinical-trial-for-easing-covid-19-complications-in-former-smokers\/","og_site_name":"KGK Science Inc.","article_publisher":"https:\/\/www.facebook.com\/KGKScience","article_published_time":"2025-02-07T20:44:59+00:00","article_modified_time":"2025-02-13T15:36:15+00:00","og_image":[{"width":2560,"height":1702,"url":"https:\/\/barsoums.ca\/kgkbeta\/wp-content\/uploads\/2025\/02\/AdobeStock_527001674-scaled.jpeg","type":"image\/jpeg"}],"author":"Claire Jack","twitter_card":"summary_large_image","twitter_creator":"@kgkscience","twitter_site":"@kgkscience","twitter_misc":{"Written by":"Claire Jack","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/barsoums.ca\/kgkbeta\/kgk-contracted-by-hofseth-biocare-for-phase-2-clinical-trial-for-easing-covid-19-complications-in-former-smokers\/#article","isPartOf":{"@id":"https:\/\/barsoums.ca\/kgkbeta\/kgk-contracted-by-hofseth-biocare-for-phase-2-clinical-trial-for-easing-covid-19-complications-in-former-smokers\/"},"author":{"name":"Claire Jack","@id":"https:\/\/barsoums.ca\/kgkbeta\/#\/schema\/person\/ed46640f8cbb9d96d274f1a6c6e8591b"},"headline":"KGK Contracted by Hofseth Biocare for Phase 2 Clinical Trial for Easing COVID-19 Complications in Former Smokers","datePublished":"2025-02-07T20:44:59+00:00","dateModified":"2025-02-13T15:36:15+00:00","mainEntityOfPage":{"@id":"https:\/\/barsoums.ca\/kgkbeta\/kgk-contracted-by-hofseth-biocare-for-phase-2-clinical-trial-for-easing-covid-19-complications-in-former-smokers\/"},"wordCount":416,"commentCount":0,"publisher":{"@id":"https:\/\/barsoums.ca\/kgkbeta\/#organization"},"image":{"@id":"https:\/\/barsoums.ca\/kgkbeta\/kgk-contracted-by-hofseth-biocare-for-phase-2-clinical-trial-for-easing-covid-19-complications-in-former-smokers\/#primaryimage"},"thumbnailUrl":"https:\/\/barsoums.ca\/kgkbeta\/wp-content\/uploads\/2025\/02\/AdobeStock_527001674-scaled.jpeg","articleSection":["Press Release"],"inLanguage":"en","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/barsoums.ca\/kgkbeta\/kgk-contracted-by-hofseth-biocare-for-phase-2-clinical-trial-for-easing-covid-19-complications-in-former-smokers\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/barsoums.ca\/kgkbeta\/kgk-contracted-by-hofseth-biocare-for-phase-2-clinical-trial-for-easing-covid-19-complications-in-former-smokers\/","url":"https:\/\/barsoums.ca\/kgkbeta\/kgk-contracted-by-hofseth-biocare-for-phase-2-clinical-trial-for-easing-covid-19-complications-in-former-smokers\/","name":"KGK Contracted by Hofseth Biocare for Phase 2 Clinical Trial for Easing COVID-19 Complications in Former Smokers - KGK Science Inc.","isPartOf":{"@id":"https:\/\/barsoums.ca\/kgkbeta\/#website"},"primaryImageOfPage":{"@id":"https:\/\/barsoums.ca\/kgkbeta\/kgk-contracted-by-hofseth-biocare-for-phase-2-clinical-trial-for-easing-covid-19-complications-in-former-smokers\/#primaryimage"},"image":{"@id":"https:\/\/barsoums.ca\/kgkbeta\/kgk-contracted-by-hofseth-biocare-for-phase-2-clinical-trial-for-easing-covid-19-complications-in-former-smokers\/#primaryimage"},"thumbnailUrl":"https:\/\/barsoums.ca\/kgkbeta\/wp-content\/uploads\/2025\/02\/AdobeStock_527001674-scaled.jpeg","datePublished":"2025-02-07T20:44:59+00:00","dateModified":"2025-02-13T15:36:15+00:00","breadcrumb":{"@id":"https:\/\/barsoums.ca\/kgkbeta\/kgk-contracted-by-hofseth-biocare-for-phase-2-clinical-trial-for-easing-covid-19-complications-in-former-smokers\/#breadcrumb"},"inLanguage":"en","potentialAction":[{"@type":"ReadAction","target":["https:\/\/barsoums.ca\/kgkbeta\/kgk-contracted-by-hofseth-biocare-for-phase-2-clinical-trial-for-easing-covid-19-complications-in-former-smokers\/"]}]},{"@type":"ImageObject","inLanguage":"en","@id":"https:\/\/barsoums.ca\/kgkbeta\/kgk-contracted-by-hofseth-biocare-for-phase-2-clinical-trial-for-easing-covid-19-complications-in-former-smokers\/#primaryimage","url":"https:\/\/barsoums.ca\/kgkbeta\/wp-content\/uploads\/2025\/02\/AdobeStock_527001674-scaled.jpeg","contentUrl":"https:\/\/barsoums.ca\/kgkbeta\/wp-content\/uploads\/2025\/02\/AdobeStock_527001674-scaled.jpeg","width":2560,"height":1702,"caption":"Male doctor looks anatomical model lung in clinic room. Working as doctor during pandemic covid 19 concept."},{"@type":"BreadcrumbList","@id":"https:\/\/barsoums.ca\/kgkbeta\/kgk-contracted-by-hofseth-biocare-for-phase-2-clinical-trial-for-easing-covid-19-complications-in-former-smokers\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/barsoums.ca\/kgkbeta\/"},{"@type":"ListItem","position":2,"name":"KGK Contracted by Hofseth Biocare for Phase 2 Clinical Trial for Easing COVID-19 Complications in Former Smokers"}]},{"@type":"WebSite","@id":"https:\/\/barsoums.ca\/kgkbeta\/#website","url":"https:\/\/barsoums.ca\/kgkbeta\/","name":"KGK Science Inc.","description":"Advancing Health &amp; Wellness Through Clinical Research","publisher":{"@id":"https:\/\/barsoums.ca\/kgkbeta\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/barsoums.ca\/kgkbeta\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en"},{"@type":"Organization","@id":"https:\/\/barsoums.ca\/kgkbeta\/#organization","name":"KGK Science Inc.","url":"https:\/\/barsoums.ca\/kgkbeta\/","logo":{"@type":"ImageObject","inLanguage":"en","@id":"https:\/\/barsoums.ca\/kgkbeta\/#\/schema\/logo\/image\/","url":"https:\/\/barsoums.ca\/kgkbeta\/wp-content\/uploads\/2024\/08\/cropped-kgk-logo.png","contentUrl":"https:\/\/barsoums.ca\/kgkbeta\/wp-content\/uploads\/2024\/08\/cropped-kgk-logo.png","width":1200,"height":529,"caption":"KGK Science Inc."},"image":{"@id":"https:\/\/barsoums.ca\/kgkbeta\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/KGKScience","https:\/\/x.com\/kgkscience","https:\/\/www.linkedin.com\/company\/kgkscienceinc.\/"]},{"@type":"Person","@id":"https:\/\/barsoums.ca\/kgkbeta\/#\/schema\/person\/ed46640f8cbb9d96d274f1a6c6e8591b","name":"Claire Jack","image":{"@type":"ImageObject","inLanguage":"en","@id":"https:\/\/secure.gravatar.com\/avatar\/65f555cf6e46eb32eed32e1c0f73bf1d2dbdfee55eacc84ccf8ff95a9566f96f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/65f555cf6e46eb32eed32e1c0f73bf1d2dbdfee55eacc84ccf8ff95a9566f96f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/65f555cf6e46eb32eed32e1c0f73bf1d2dbdfee55eacc84ccf8ff95a9566f96f?s=96&d=mm&r=g","caption":"Claire Jack"},"url":"https:\/\/barsoums.ca\/kgkbeta\/author\/cjack\/"}]}},"_links":{"self":[{"href":"https:\/\/barsoums.ca\/kgkbeta\/wp-json\/wp\/v2\/posts\/2027","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/barsoums.ca\/kgkbeta\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/barsoums.ca\/kgkbeta\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/barsoums.ca\/kgkbeta\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/barsoums.ca\/kgkbeta\/wp-json\/wp\/v2\/comments?post=2027"}],"version-history":[{"count":1,"href":"https:\/\/barsoums.ca\/kgkbeta\/wp-json\/wp\/v2\/posts\/2027\/revisions"}],"predecessor-version":[{"id":2028,"href":"https:\/\/barsoums.ca\/kgkbeta\/wp-json\/wp\/v2\/posts\/2027\/revisions\/2028"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/barsoums.ca\/kgkbeta\/wp-json\/wp\/v2\/media\/2637"}],"wp:attachment":[{"href":"https:\/\/barsoums.ca\/kgkbeta\/wp-json\/wp\/v2\/media?parent=2027"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/barsoums.ca\/kgkbeta\/wp-json\/wp\/v2\/categories?post=2027"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/barsoums.ca\/kgkbeta\/wp-json\/wp\/v2\/tags?post=2027"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}